Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim PharmafiledCriticalBoehringer Ingelheim Pharma
Priority to UY26904ApriorityCriticalpatent/UY26904A1/en
Publication of UY26904A1publicationCriticalpatent/UY26904A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La presente invención se refiere a heterociclos bicíclicos de la fórmula general (I) en la que Ra a Rd y X están definidos como en la reivindicación 1, a sus tautómeros, sus estereoisómeros y sus sales, en particular sus sales fisiológicamente compatibles con ácidos o bases inorgánicos u orgánicos, que presentan valiosas propiedades farmacológicas, en particular un efecto inhibidor sobre la transducción de senales inducida por tirosinaquinasas, a su empleo para el tratamiento de enfermedades, en particular de enfermedades tumorales, de enfermedades de los pulmones y de las vías respiratorias, y a su preparaciónThe present invention relates to bicyclic heterocycles of the general formula (I) in which Ra to Rd and X are defined as in claim 1, their tautomers, their stereoisomers and their salts, in particular their physiologically compatible salts with acids or inorganic or organic bases, which have valuable pharmacological properties, in particular an inhibitory effect on tyrosine kinase-induced signal transduction, for use in the treatment of diseases, in particular tumor diseases, lung diseases and respiratory tract diseases , and its preparation
UY26904A2001-08-232001-08-23
BICYCLIOC HETEROCYCLES, MEDICATIONS CONTAINING THESE COMPOUNDS, THEIR EMPLOYMENT AND PROCEDURE FOR PREPARATION
UY26904A1
(en)
PIRIMIDO [5,4-D] PYRIMIDINES, THEIR PHYSIOLOGICALLY COMPATIBLE SALTS, A PROCEDURE FOR THEIR PREPARATION, THEIR USE FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS, AND THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM